Literature DB >> 33883471

Reaching Those Most at Risk for HIV Acquisition: Evaluating Racial/Ethnic Disparities in the Preexposure Prophylaxis Care Continuum in Baltimore City, Maryland.

Christina M Schumacher1, Xueting Tao1, Aruna Chandran2, Errol Fields1, Ashley Price3, Adena Greenbaum3, Jacky M Jennings1,2.   

Abstract

BACKGROUND: Reducing HIV incidence requires addressing persistent racial/ethnic disparities in HIV burden. Our goal was to evaluate preexposure prophylaxis (PrEP) delivery, overall and relative to community need, among 7 clinical sites participating in a health department-led demonstration project to increase PrEP in Baltimore city, MD.
METHODS: PrEP care continuum stages (screened, indicated, referred, linked, evaluated, prescribed) were examined among HIV-negative individuals receiving services at participating sites between September 30, 2015 and September 29, 2019. Community need was defined using information on new HIV diagnoses (2016-2018). Differences in care continuum progression by demographics/priority population and comparison of demographic compositions between care continuum stages and new HIV diagnoses were examined using modified Poisson regression and χ2 tests, respectively.
RESULTS: Among 25,886 PrEP-screened individuals, the majority were non-Hispanic (NH) black (81.1%, n = 20,998), cisgender male (61.1%, n = 15,825), and heterosexual (86.7%, n = 22,452). Overall, 31.1% (n = 8063) were PrEP-indicated; among whom, 56.8% (n = 4578), 15.6% (n = 1250), 10.8% (n = 868), and 9.0% (n = 722) were PrEP-referred, linked, evaluated, and prescribed, respectively. Among 2870 men who have sex with men (MSM), 18.7% (n = 538) were PrEP-prescribed. Across all groups, the highest attrition was between PrEP-referred and PrEP-linked. NH-black race (vs. NH-white) was independently associated with lower likelihood of PrEP prescription (aPR, 0.89; 95% confidence interval, 0.81 to 0.98 controlling for age/gender). Relative to the demographic composition of new HIV diagnoses, fewer NH-blacks (80.2% vs. 54.3%) and more NH-whites (10.7% vs. 30.3%) and MSM were PrEP prescribed (55.2% vs. 74.5%).
CONCLUSIONS: This project showed promise delivering PrEP referrals and prescriptions overall and to MSM. Substantial improvement is needed to improve linkage overall and to decrease disparities in PrEP prescriptions among NH-blacks. Future work should focus on addressing service gaps that hinder PrEP utilization.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33883471      PMCID: PMC9306005          DOI: 10.1097/QAI.0000000000002712

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.771


  33 in total

1.  Dramatic increase in preexposure prophylaxis use among MSM in Washington state.

Authors:  Julia E Hood; Susan E Buskin; Julia C Dombrowski; David A Kern; Elizabeth A Barash; David A Katz; Matthew R Golden
Journal:  AIDS       Date:  2016-01-28       Impact factor: 4.177

2.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

3.  Community-level changes in condom use and uptake of HIV pre-exposure prophylaxis by gay and bisexual men in Melbourne and Sydney, Australia: results of repeated behavioural surveillance in 2013-17.

Authors:  Martin Holt; Toby Lea; Limin Mao; Johann Kolstee; Iryna Zablotska; Tim Duck; Brent Allan; Michael West; Evelyn Lee; Peter Hull; Andrew Grulich; John De Wit; Garrett Prestage
Journal:  Lancet HIV       Date:  2018-06-06       Impact factor: 12.767

4.  Implementation of Preexposure Prophylaxis for Human Immunodeficiency Virus Prevention Among Men Who Have Sex With Men at a New England Sexually Transmitted Diseases Clinic.

Authors:  Philip A Chan; Tiffany R Glynn; Catherine E Oldenburg; Madeline C Montgomery; Ashley E Robinette; Alexi Almonte; Julia Raifman; Leandro Mena; Rupa Patel; Kenneth H Mayer; Laura S Beauchamps; Amy S Nunn
Journal:  Sex Transm Dis       Date:  2016-11       Impact factor: 2.830

5.  Awareness and Acceptability of Pre-exposure HIV Prophylaxis Among Men Who have Sex with Men in Baltimore.

Authors:  Susan A Fallon; Ju Nyeong Park; Christine Powell Ogbue; Colin Flynn; Danielle German
Journal:  AIDS Behav       Date:  2017-05

6.  Outcomes of Preexposure Prophylaxis Referrals From Public STI Clinics and Implications for the Preexposure Prophylaxis Continuum.

Authors:  Ramona Bhatia; Laxmi Modali; Matthew Lowther; Nancy Glick; Margo Bell; Sarah Rowan; Kristin Keglovitz; John Schneider
Journal:  Sex Transm Dis       Date:  2018-01       Impact factor: 2.830

7.  The HIV Pre-exposure Prophylaxis (PrEP) Cascade at NYC Sexual Health Clinics: Navigation Is the Key to Uptake.

Authors:  Preeti Pathela; Kelly Jamison; Susan Blank; Demetre Daskalakis; Trevor Hedberg; Christine Borges
Journal:  J Acquir Immune Defic Syndr       Date:  2020-04-01       Impact factor: 3.731

8.  The Pre-exposure Prophylaxis (PrEP) Care Cascade in People Who Inject Drugs: A Systematic Review.

Authors:  Colleen B Mistler; Michael M Copenhaver; Roman Shrestha
Journal:  AIDS Behav       Date:  2021-05

9.  Effect of Racial Inequities in Pre-exposure Prophylaxis Use on Racial Disparities in HIV Incidence Among Men Who Have Sex With Men: A Modeling Study.

Authors:  William C Goedel; Maximilian R F King; Mark N Lurie; Amy S Nunn; Philip A Chan; Brandon D L Marshall
Journal:  J Acquir Immune Defic Syndr       Date:  2018-11-01       Impact factor: 3.771

10.  HIV Preexposure Prophylaxis, by Race and Ethnicity - United States, 2014-2016.

Authors:  Ya-Lin A Huang; Weiming Zhu; Dawn K Smith; Norma Harris; Karen W Hoover
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-10-19       Impact factor: 17.586

View more
  2 in total

1.  An Open-Label Pharmacokinetic and Pharmacodynamic Assessment of Tenofovir Gel and Oral Emtricitabine/Tenofovir Disoproxil Fumarate.

Authors:  Ian M McGowan; Ratiya Pamela Kunjara Na Ayudhya; Rhonda M Brand; Mark A Marzinke; Craig W Hendrix; Sherri Johnson; Jeanna Piper; Timothy H Holtz; Marcel E Curlin; Anupong Chitwarakorn; Boonyos Raengsakulrach; Gustavo Doncel; Jill L Schwartz; James F Rooney; Ross D Cranston
Journal:  AIDS Res Hum Retroviruses       Date:  2021-10-29       Impact factor: 1.723

2.  HIV Transmission Potential and Sex Partner Concurrency: Evidence for Racial Disparities in HIV Risk Among Gay and Bisexual Men (MSM).

Authors:  Carla Tilchin; Jessica Wagner; Christina M Schumacher; Khalil G Ghanem; Matthew M Hamill; Anne Rompalo; Errol Fields; Carl A Latkin; Adena Greenbaum; Jacky M Jennings
Journal:  AIDS Behav       Date:  2021-08-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.